Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IlEucVari

ABSTRACT: Euchalcia variabilis (purple-shaded gem)

PROVIDER: PRJEB78804 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR13494005_1.fastq.gz	Fastqsanger.gz
	ERR13494005_2.fastq.gz	Fastqsanger.gz
	ERR13485748.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

ilEucVari

Project description:Euchalcia variabilis (purple-shaded gem), genomic and transcriptomic data

| PRJEB78803 | ENA

ilEucVari1 hap2

Project description:Euchalcia variabilis (purple-shaded gem) genome assembly, ilEucVari1 haplotype 2

| PRJEB79394 | ENA

ilEucVari1 hap1

Project description:Euchalcia variabilis (purple-shaded gem) genome assembly, ilEucVari1 haplotype 1

| PRJEB79395 | ENA

Euchalcia variabilis

Project description:Euchalcia variabilis overview

| PRJNA1153694 | ENA

Whole-genome transcriptome analysis of tomato and Arabidopsis roots in the shade

Project description:RNA-seq analysis of arabidopsis and tomato roots in shaded and unshaded seedlings.

2023-08-08 | GSE175963 | GEO

Targeting gut microbiota in Kras wild-type and G12D mutated pancreatic cancer mice

Project description:FastQ files from 16S sequencing of fecal samples from pancreatic cancer xenografted mice not treated (CTRL) and treated with chemotherapy (GEM+nab-PTX), probiotics (PRO) and chemotherapy + probiotics (GEM+nab-PTX+PRO)

2024-09-14 | E-MTAB-12171 | biostudies-arrayexpress

microRNA Expression profiles of parental Panc1 cell lines and Gemcitabine resistance Panc1 cell lines

Project description:Gemcitabine (GEM) is a key drug for treating PDAC, and it is commonly used for adjuvant chemotherapy. Although the majority of PDAC is sensitive to GEM at first, GEM cannot control PDAC for very long, suggesting that PDAC develops resistance to GEM after prolonged exposure. No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma. MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. This study assesses gemcitabine resistant PDAC for its specific miR expression pattern. Gemcitabine resistant variants of Panc1, a human pancreatic adenocarcinoma cell line, were established. MicroRNA screening was investigated by microarray.

2016-04-26 | GSE80616 | GEO

GEM-CESAR

Project description:GEM-CESAR

| PRJEB72353 | ENA

Sensitivity of cholangiocarcinoma cells to gemcitabine is affected by microRNA expression

Project description:We examined the relationship between miRNA expression and the sensitivity of CCA cells to Gem. Two intrahepatic CCA cell lines, HuH28 and HuCCT1 were used. HuCCT1 cells were more sensitive to Gem than were HuH28 cells. The miRNA expression profiles of HuH28 and HuCCT1 were determined by microarray analysis. Eighteen miRNAs were differentially expressed whose ratios over ± 2log2 between HuH28 and HuCCT1. Among these 18 miRNAs, ectopic overexpression of each of three downregulated miRNAs in HuH28 (miR-29b, miR-205, miR-221) restored Gem sensitivity to HuH28. Suppression of one upregulated miRNA in HuH28, miR-125a-5p, inhibited HuH28 cell proliferation independently to Gem treatment.

2013-06-02 | GSE47396 | GEO

ilEupSubu

Project description:Eupithecia subumbrata (shaded pug)

| PRJEB59792 | ENA